Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 3:09 pm Purchase |
2021-12-31 | 13G | Veracyte, Inc. VCYT |
ARK Investment Management LLC | 8,222,281 11.570% |
335,087 (+4.25%) |
Filing History |
| 2022-02-09 3:08 pm Sale |
2021-12-31 | 13G | Twist Bioscience Corporation TWST |
ARK Investment Management LLC | 3,767,203 7.590% |
-2,109,768 (-35.90%) |
Filing History |
| 2022-02-09 3:06 pm Purchase |
2021-12-31 | 13G | Teladoc Health, Inc. TDOC |
ARK Investment Management LLC | 18,922,198 11.820% |
3,279,390 (+20.96%) |
Filing History |
| 2022-02-09 3:04 pm Purchase |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
ARK Investment Management LLC | 5,326,127 11.540% |
849,707 (+18.98%) |
Filing History |
| 2022-02-09 3:02 pm Purchase |
2021-12-31 | 13G | Stratasys Ltd. SSYS |
ARK Investment Management LLC | 7,654,932 11.690% |
280,431 (+3.80%) |
Filing History |
| 2022-02-09 3:00 pm Purchase |
2021-12-31 | 13G | Signify Health, Inc. SGFY |
ARK Investment Management LLC | 20,010,328 11.740% |
2,076,338 (+11.58%) |
Filing History |
| 2022-02-09 2:59 pm Purchase |
2021-12-31 | 13G | Quantum-Si incorporated QSI |
ARK Investment Management LLC | 13,067,150 11.120% |
1,404,125 (+12.04%) |
Filing History |
| 2022-02-09 2:48 pm Sale |
2021-12-31 | 13G | Personalis, Inc. PSNL |
ARK Investment Management LLC | 4,888,115 10.910% |
-1,890,508 (-27.89%) |
Filing History |
| 2022-02-09 2:47 pm Purchase |
2021-12-31 | 13G | PagerDuty, Inc. PD |
ARK Investment Management LLC | 10,020,916 11.650% |
23,948 (+0.24%) |
Filing History |
| 2022-02-09 2:45 pm Sale |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 26,383,103 11.960% |
-2,121,526 (-7.44%) |
Filing History |
| 2022-02-09 2:44 pm Purchase |
2021-12-31 | 13G | Materialise NV MTLS |
ARK Investment Management LLC | 6,128,880 11.310% |
518,067 (+9.23%) |
Filing History |
| 2022-02-09 2:42 pm Sale |
2021-12-31 | 13G | Iridium Communications Inc. IRDM |
ARK Investment Management LLC | 10,136,671 7.670% |
-3,513,207 (-25.74%) |
Filing History |
| 2022-02-09 2:40 pm Purchase |
2021-12-31 | 13G | Invitae Corporation NVTAQ |
ARK Investment Management LLC | 26,700,813 11.800% |
782,927 (+3.02%) |
Filing History |
| 2022-02-09 2:38 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 7,916,882 10.640% |
274,430 (+3.59%) |
Filing History |
| 2022-02-09 2:37 pm Sale |
2021-12-31 | 13G | Fate Therapeutics, Inc. FATE |
ARK Investment Management LLC | 10,312,167 10.800% |
-478,256 (-4.43%) |
Filing History |
| 2022-02-09 2:35 pm Sale |
2021-12-31 | 13G | Evogene Ltd. EVGN |
ARK Investment Management LLC | 251,566 6.010% |
-207,884 (-45.25%) |
Filing History |
| 2022-02-09 2:32 pm Sale |
2021-12-31 | 13G | Editas Medicine, Inc. EDIT |
ARK Investment Management LLC | 4,218,302 6.170% |
-5,907,262 (-58.34%) |
Filing History |
| 2022-02-09 2:31 pm Sale |
2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS |
ARK Investment Management LLC | 2,362,677 9.960% |
-15,026 (-0.63%) |
Filing History |
| 2022-02-09 2:29 pm Purchase |
2021-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 9,087,868 11.880% |
1,443,518 (+18.88%) |
Filing History |
| 2022-02-09 2:27 pm Sale |
2021-12-31 | 13G | Concord Acquisition Corp CND |
ARK Investment Management LLC | 3,172,501 11.190% |
-139,783 (-4.22%) |
Filing History |